Scientists have has pioneered antivirals targeting viral methyltransferases, offering a new strategy for treating RNA and DNA ...

The Centers for Disease Control and Prevention called it the first severe case in the U.S., though the risk to most of the public is still low.

New York and Copenhagen–based start-up HERVolution Therapeutics has raised $11.7 million in series A financing. The company ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35 ...

Key findings from 2024 focused on conditions like vaccine-induced immune thrombotic thrombocytopenia, immune thrombocytopenia ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

Since the COVID-19 pandemic, considerable advances have been made to improve epidemic preparedness by accelerating ...

This study reveals how SARS-CoV-2 infection significantly alters human milk composition, while COVID-19 vaccination causes ...

However, the vaccine and its manufacturers received criticism because it was less effective than the mRNA Covid vaccines ...

A woman from Scotland has become the first patient in Europe to receive a cancer jab for gastro-oesophageal cancer. Jennifer ...